International Biotechnology (IBT) Competitors GBX 706 +16.00 (+2.32%) As of 09/19/2025 11:53 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock IBT vs. JEO, ICGT, APEO, MUT, TFIF, SAIN, SDP, SLPE, RICA, and CGTShould you be buying International Biotechnology stock or one of its competitors? The main competitors of International Biotechnology include European Opportunities Trust (JEO), ICG Enterprise Trust (ICGT), abrdn Private Equity Opportunities (APEO), Murray Income Trust (MUT), TwentyFour Income (TFIF), Scottish American Investment (SAIN), Schroder Investment Trust - Schroder AsiaPacific Fund (SDP), Standard Life Private Equity Trust (SLPE), Ruffer Investment (RICA), and Capital Gearing (CGT). These companies are all part of the "asset management" industry. International Biotechnology vs. Its Competitors European Opportunities Trust ICG Enterprise Trust abrdn Private Equity Opportunities Murray Income Trust TwentyFour Income Scottish American Investment Schroder Investment Trust - Schroder AsiaPacific Fund Standard Life Private Equity Trust Ruffer Investment Capital Gearing European Opportunities Trust (LON:JEO) and International Biotechnology (LON:IBT) are both small-cap asset management industry companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, media sentiment, institutional ownership, risk and earnings. Do insiders & institutionals believe in JEO or IBT? 7.9% of International Biotechnology shares are held by institutional investors. 1.0% of International Biotechnology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has better valuation and earnings, JEO or IBT? International Biotechnology has higher revenue and earnings than European Opportunities Trust. European Opportunities Trust is trading at a lower price-to-earnings ratio than International Biotechnology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEuropean Opportunities Trust-£62.33M0.00N/A-£65.20N/AInternational Biotechnology£18.57M12.82£37.91M£0.481,460.49 Does the media prefer JEO or IBT? In the previous week, International Biotechnology had 1 more articles in the media than European Opportunities Trust. MarketBeat recorded 1 mentions for International Biotechnology and 0 mentions for European Opportunities Trust. International Biotechnology's average media sentiment score of 0.75 beat European Opportunities Trust's score of 0.00 indicating that International Biotechnology is being referred to more favorably in the news media. Company Overall Sentiment European Opportunities Trust Neutral International Biotechnology Positive Is JEO or IBT a better dividend stock? European Opportunities Trust pays an annual dividend of GBX 0.04 per share. International Biotechnology pays an annual dividend of GBX 0.30 per share and has a dividend yield of 0.0%. European Opportunities Trust pays out -0.1% of its earnings in the form of a dividend. International Biotechnology pays out 62.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Is JEO or IBT more profitable? International Biotechnology has a net margin of 90.66% compared to European Opportunities Trust's net margin of 0.00%. International Biotechnology's return on equity of 13.67% beat European Opportunities Trust's return on equity.Company Net Margins Return on Equity Return on Assets European Opportunities TrustN/A N/A N/A International Biotechnology 90.66%13.67%3.57% SummaryInternational Biotechnology beats European Opportunities Trust on 11 of the 12 factors compared between the two stocks. Get International Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for IBT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBT vs. The Competition Export to ExcelMetricInternational BiotechnologyAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£226.11M£1.48B£5.99B£2.57BDividend Yield4.69%4.61%4.32%5.31%P/E Ratio1,460.494,723.751,769.445,389.17Price / Sales12.821,963.801,360.0197,580.70Price / Cash155.7460.47127.9627.93Price / Book0.921.372.089.20Net Income£37.91M£264.59M£1.23B£5.89B7 Day Performance2.32%0.20%1.11%0.71%1 Month Performance6.01%1.59%3.00%3.21%1 Year Performance1.73%9.23%34.21%196.53% International Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBTInternational BiotechnologyN/AGBX 706+2.3%N/A+1.7%£226.11M£18.57M1,460.49N/ANews CoverageJEOEuropean Opportunities TrustN/AN/AN/AN/A£886.70M-£62.33M-12.93N/AICGTICG Enterprise TrustN/AGBX 1,402+0.1%N/A+18.7%£881.49M£117.70M855.87N/AAPEOabrdn Private Equity OpportunitiesN/AN/AN/AN/A£880.29M£80.21M1,435.00N/AMUTMurray Income TrustN/AGBX 895.50+0.4%N/A+3.5%£876.62M£27.79M3,685.19147,000News CoveragePositive NewsEarnings ReportDividend CutTFIFTwentyFour IncomeN/AGBX 113.40+0.2%N/A+6.2%£872.09M£106.24M810.00N/ASAINScottish American InvestmentN/AGBX 507.70+0.1%N/A-0.4%£859.33M£13.77M8,922.60N/ASDPSchroder Investment Trust - Schroder AsiaPacific FundN/AGBX 633+1.0%N/A+23.4%£857.21M£55.98M1,997.48N/ANews CoveragePositive NewsSLPEStandard Life Private Equity TrustN/AGBX 555+0.2%N/A+1.7%£853.29M£289.51M298.07N/ANews CoverageRICARuffer InvestmentN/AGBX 286.12+0.0%N/A+4.4%£852.85M-£2.33M-19,869.17N/ANews CoveragePositive NewsCGTCapital GearingN/AGBX 4,871.48+0.2%N/A+1.9%£819.82M£37.55M2,709.39N/A Related Companies and Tools Related Companies European Opportunities Trust Competitors ICG Enterprise Trust Competitors abrdn Private Equity Opportunities Competitors Murray Income Trust Competitors TwentyFour Income Competitors Scottish American Investment Competitors Schroder Investment Trust - Schroder AsiaPacific Fund Competitors Standard Life Private Equity Trust Competitors Ruffer Investment Competitors Capital Gearing Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IBT) was last updated on 9/21/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBT Stock Alerts